Cellectar Biosciences Partners with Evestia Clinical for Phase 1b Trial of CLR 125 in Triple-Negative Breast Cancer Read more
FDA Grants Priority Review to AstraZeneca and Daiichi Sankyo’s Enhertu for First-Line HER2-Positive Metastatic Breast Cancer Read more
Sanofi Boosts Sanofi Ventures with $625M to Accelerate Biotech and Digital Health Investments Read more
Merck and Siemens Extend Strategic Partnership to Drive Digital Transformation in Life Sciences Read more
TegMine Therapeutics Partners with Boehringer Ingelheim to Develop Next-Gen Targeted Cancer Therapies Read more